Anzeige
Mehr »
Lynx Broker
Login
Mittwoch, 18.09.2019 Börsentäglich über 12.000 News von 610 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0EAT9 ISIN: BE0003818359 Ticker-Symbol: GXE 
Tradegate
17.09.19
18:04 Uhr
143,90 Euro
+0,05
+0,03 %
Branche
Biotechnologie
Aktienmarkt
BEL-20
AEX
1-Jahres-Chart
GALAPAGOS NV Chart 1 Jahr
5-Tage-Chart
GALAPAGOS NV 5-Tage-Chart
RealtimeGeldBriefZeit
143,95
144,60
08:46
143,95
144,05
08:46

Aktuelle News zur GALAPAGOS NV Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.09.DGAP-Adhoc: Galapagos S.A.: Court Order2.039EQS-Ad-hoc: Galapagos S.A. / Key word(s): Legal Matter Galapagos S.A.: Court Order 10-Sep-2019 / 12:55 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation...
► Artikel lesen
09.09.Morgan Stanley sees 23% upside in Galapagos in premarket analyst action20
GALAPAGOS NV Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!
05.09.GALAPAGOS NV - 6-K, Report of foreign issuer7
03.09.Galapagos-Insolvenz: Britisch-deutscher Clinch um den Verfahrensort34
30.08.Galapagos NV: Transparency notification296Mechelen, Belgium; 30 August 2019; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V. Pursuant to Belgian...
► Artikel lesen
29.08.GALAPAGOS NV - 6-K, Report of foreign issuer1
28.08.Galapagos NV: Transparency notification - Gilead holds 22% of Galapagos shares388Mechelen, Belgium; 28 August 2019; 22.01 CEST; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc. Pursuant to Belgian...
► Artikel lesen
27.08.Gilead & Galapagos Close Research & Development Agreement24
26.08.BRIEF-Galapagos Files Application To Initiate Insolvency Proceedings32
26.08.Gilead, Galapagos finalise £4.1bn research and development deal20
25.08.DGAP-Adhoc: Galapagos S.A.: Insolvency2.271EQS-Ad-hoc: Galapagos S.A. / Key word(s): Personnel/Insolvency Galapagos S.A.: NOTICE 25-Aug-2019 / 17:15 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of...
► Artikel lesen
23.08.Gilead and Galapagos consummate R&D partnership15
23.08.Galapagos NV: Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration964Foster City, Calif. and Mechelen, Belgium; 23 August 2019; 22.01 CET; regulated information - Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced the closing...
► Artikel lesen
15.08.Galapagos NV: European Medicines Agency validates marketing application for filgotinib for the treatment of rheumatoid arthritis482Foster City, Calif. and Mechelen, Belgium - August 15, 2019 22.01 CET - Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Marketing Authorization...
► Artikel lesen
05.08.Here's Why Galapagos NV Rose 34.5% in July10
31.07.Gilead looks to Galapagos deal to double research capacity25
26.07.Galapagos NV (GLPG) CEO Onno van de Stolpe on Q2 2019 Results - Earnings Call Transcript6
26.07.Galapagos reports Q2 results7
25.07.GALAPAGOS NV - 6-K, Report of foreign issuer3
25.07.Galapagos NV: Strong clinical progress in H1 and transformative collaboration with Gilead announced223First half-year financial results: Group revenues of €108.5 million Operating loss of €97.6 million Net loss...
► Artikel lesen
Seite:  Weiter >>
144 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
2,1,3